Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Stepping back to the early 1960s, researchers felt a desperate need for dependable pH buffers, especially with biological and medical work speeding up. People ran into trouble using simple salts and weak acids, finding their reactions often unpredictable and sometimes even toxic. Enter 4-hydroxyethylpiperazine ethanesulfonic acid—better known as HEPES. Dr. Norman Good and his colleagues at Rockefeller University gave this buffer its earliest mention, aiming for a compound that worked in the narrow pH zone where enzymes kept ticking and cells stayed alive. Over the next decade, word spread across bench tops, and soon scientific communities from Boston to Bangalore started asking for HEPES by name for cell culture and protein studies. The buffer didn’t just stick around; it became essential gear for any serious biochemist, and its story still rolls on in today’s pharma labs.
HEPES comes as a solid, usually in a white crystalline form. Most labs stock it in powder bottles, labeled for pharma or molecular work. It dissolves easily in water, with hardly any fuss, which makes prep straightforward. Pretty much every major supplier offers HEPES in several grades, with pharma grade making sure it clears tight rules for contaminants and meets pharmacopeial standards—these come marked BP, EP, or USP, depending on the region. Folks dealing with injectable drugs or sensitive diagnostics pick pharma grade without hesitation, since any slip in quality here invites big trouble downstream.
HEPES tips the scale with a molecular weight of about 238.3 g/mol. It stays odorless and keeps its color, which saves researchers a headache when watching for contamination. The melting point hovers above 200°C, and HEPES acts as a zwitterion—a molecule carrying both positive and negative charges—which helps it lock down pH in a tight range, usually 6.8 to 8.2. What matters most is HEPES doesn’t react with calcium, magnesium, or other ions too easily, and with its high buffering capacity, the solution never drifts off-point, even with cell cultures sitting for days. Shelf life stays generous if moisture stays out, and temperature swings don’t wreck its performance either.
Pharma grade HEPES must pass tough specs. Impurities like heavy metals, chlorides, and sulfates need to stay far below the limits detailed in BP, EP, or USP monographs. Labs check the substance for identity by infrared absorption and compare it against a reference standard. Moisture content can’t climb higher than about 0.5%. The labeling on pharma-grade drums gives the full chemical name, CAS number (7365-45-9), batch number, expiration date, and a statement of compliance. For companies facing audits, these details mean more than just paperwork—they anchor traceability. The container avoids dust and light, with tamperproof sealing, since a single speck of contamination could ruin a biotech run worth millions.
Industrial production of HEPES usually starts from piperazine, a basic building block in organic chemistry. Chemists add a hydroxyethyl side chain, then tack on an ethanesulfonic acid group through controlled reactions, usually monitored by HPLC or TLC for completion. Final purification uses recrystallization and washing to clear out byproducts and leftover solvents. QA teams test the bulk powder at several stages, since just a trace of leftover solvent or a wrong isomer causes headaches for downstream users. In well-run plants, quality teams run FT-IR and NMR checks before releasing any batch for sale.
HEPES holds up well under most cell culture and drug formulation conditions. It resists breakdown from light and ordinary heat, and its zwitterionic nature keeps unwanted reaction partners from interfering with protein or DNA work. In rare cases, scientists tweak the molecule with small substitutions to shift the buffering range a notch higher or lower. HEPES derivatives show up in custom biological reagents, especially where specific labeling or enhanced solubility helps. The sulfonic acid group survives most typical lab reactions, offering room for creative chemical modifications in advanced research units.
The core name stays 4-hydroxyethylpiperazine ethanesulfonic acid, but users find it marketed under synonyms like HEPES, N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid, and sometimes “Good’s Buffer B.” Major suppliers keep branding simple to avoid mix-ups, since confusion can stall work or spoil results. Scientists swapping stories on research forums usually stick with HEPES, since the shorthand cuts through chemistry jargon fast.
In pharma-grade facilities, safety means keeping dust levels down, using gloves, and filtering air around weighing stations. HEPES doesn’t cause toxic fumes, but dust inhalation or direct contact with eyes causes mild irritation. The compound doesn’t burn or explode under typical conditions, though storage rooms stick with low humidity to protect shelf life. Cleaning up spills requires basic PPE and regular training, since careless handling in production settings risks cross-contamination. Regulatory authorities expect documented handling and SOPs for every batch, especially in cleanroom spaces shared with injectable drug ingredients.
Most researchers see HEPES as a buffer for cell culture media, especially mammalian cells—its low toxicity and stable pH shine where even slight acidity swings cut into results. Hospitals and clinical labs turn to HEPES for diagnostic reagents, especially blood gas analysis and enzyme testing. Biotechs use it in vaccine production, in-vitro fertilization, and monoclonal antibody work, since many other buffers crash protein structure or mask active sites. In DNA and RNA studies, the buffer keeps nucleic acids stable during tricky extractions or incubations. Some drug makers even slip HEPES into injectables and biologicals, provided the grade meets pharmacopoeia benchmarks. Its reliability matters most in places where lab results translate to real patient care.
Labs keep pushing HEPES into new applications. Scientists test it in tissue engineering, where nerve and stem cell cultures demand almost surgical control over pH. Vaccine makers bet on HEPES for cell-based virus growth, since it fends off pH swings even as immune stimuli or growth factors tip the flask. Diagnostic test makers find HEPES a solid bet for next-generation assays, including rapid tests for infectious diseases. As gene therapy and mRNA vaccines gain momentum, developers reexamine buffer systems, including HEPES, to keep complex biologics robust from manufacturing to patient dose. Journals chart new uses every year, reporting finer pH targets or clever combo buffers.
Toxicologists pay close attention to what trace levels of HEPES do inside the body. Most animal and in-vitro studies show it causes little to no cellular toxicity at normal concentrations. Unlike other buffering agents, HEPES doesn’t upend membrane potential in delicate cell types, and metabolic breakdown inside living cells stays limited. Chronic or accidental high-dose exposure, including injection, runs the risk of acidosis or mild metabolic shifts, but such instances rarely occur outside research settings. The main toxic concern turns on its purity—any slip in synthesis or storage may introduce side products not covered by standard toxicity profiles. Long-term studies reassure most end users, and regulators nod through its inclusion in top-tier molecular biology and drug testing labs.
Looking ahead, industry trends suggest more demand for ultra-pure HEPES to support advanced biomanufacturing, cell therapy, and personalized medicine. Regulatory scrutiny will only sharpen, pushing producers toward cleaner syntheses and more transparent supply chains. Researchers want HEPES variants with narrower pKa windows or safer breakdown products for long-term human use. Sustainability also creeps into the conversation, urging the search for greener production methods and better packaging. Startups focused on diagnostic kits and bioengineering choose buffers like HEPES for reliability, but expect clear data sheets, fast delivery, and robust support from suppliers. The pressure stays on for high standards, with new directions emerging at the crossroads of pharma, diagnostics, and synthetic biology.
HEPES, short for 4-Hydroxyethylpiperazine Ethanesulfonic Acid, often shows up in a place the public rarely sees—pharmaceutical labs. People may not recognize its long name, but scientists know HEPES for its knack at keeping solutions stable and reliable, especially when testing or making medicines.
Many lab compounds change their function if the surrounding pH jumps up or drops down. Proteins, enzymes, even cell cultures become unreliable if their environment shifts out of their comfort zone. In my experience, changes like that can ruin days’ worth of work. HEPES, by design, acts as a buffer. It keeps the pH steady and gives researchers more control, which means clearer, more trusted results.
Some buffers bump into trouble inside cell cultures because of the chemicals cells pump out as they grow. HEPES stands out because it doesn’t interfere with cell growth or throw off test results. That makes it the go-to choice for anyone growing mammalian cells or handling sensitive proteins. Compared to older buffers like bicarbonate, HEPES stays effective without requiring a special mix of gas or tricky setups. It works well in open air, making things simpler and less expensive for teams working on tight budgets.
Clinical trials put a premium on accuracy and reproducibility. Every step in the process, from mixing to testing, relies on the assumption that what happens to one batch happens to all batches the same way. HEPES offers that consistency. In a world where variations as small as a few tenths of a pH unit might hide the effects of a drug, buffers like HEPES let researchers trust their data instead of second-guessing every odd result.
Drug companies often use HEPES at several stages—right from early research to final formulation. As a buffer, it shines in protein and antibody production, which gets more common every year thanks to new therapies for cancer, autoimmune disorders, and rare diseases. Antibodies fall apart or clump if exposed to unstable environments. HEPES helps protect them, so the final medicine works as intended.
Some vaccine makers choose HEPES for cell-based production systems. The COVID-19 vaccine race made this kind of technology more visible. These systems depend on tight control of cell growth conditions, and HEPES keeps the environment steady without hidden side reactions. It’s often tasteless and odorless, so finished products avoid strange flavors—important for injectables and oral drugs alike.
Every chemical in a drug recipe needs careful review, and HEPES is no exception. Some research flags the potential for trouble if HEPES breaks down and forms by-products—especially during sterilization. My conversations with quality experts made it clear: rigorous testing and choosing the right manufacturing process go a long way to reduce these risks. Regulatory agencies check for buffer safety, so every batch meets the same high bar.
HEPES stays in demand year after year because people trust the results it supports. The real trick lies in understanding how HEPES fits specific processes and choosing suppliers with a proven history. Like a favorite tool in a mechanic’s kit, HEPES helps pharmaceutical teams get to answers faster, cheaper, and with fewer headaches along the way.
Walk into any cell culture lab, and a buffer like HEPES counts as a staple. Researchers count on it for its steady pH support, especially in long experiments. Cell health often hinges on what goes into the flask. If a buffer harbors unseen contaminants, cell growth patterns may shift or, worse, results get skewed. Science owes a lot to the fine print surrounding chemical purity. Trust flows from batch-to-batch consistency, and for that, international standards lay down specs that producers follow.
The British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) set the bar for what “pure” really means. Each wrote detailed rules for HEPES, based on years of research and the collective caution of the scientific community. Their requirements don’t match word-for-word, but they all focus on practical aspects—actual things that can spoil a buffer’s use in sensitive work.
I’ve seen experiments that turned messy just because someone chose a cheaper, off-spec batch of buffer. That headache highlights why these global pharmacopeias remain trusted benchmarks.
Purity in HEPES centers on a few key checks: appearance, identity, pH, water content, heavy metals, related substances, and assay values. Let’s go into a few:
Good science doesn’t take shortcuts. Too many rushed cell culture runs have suffered from buffer oddities, leading to costly delays and suspect data. Pharmacopoeia-grade HEPES costs more than technical-grade, but that margin covers peace of mind. Anyone who’s chased phantom contaminants understands that trust in a supply bottle enables trust in results.
Suppliers show their quality game by offering detailed certificates, batch testing, and transparency with audit reports. Labs should always review the latest BP, EP, and USP documents, because periodic updates mean better coverage of contaminants as testing tech improves.
Labs can protect results by buying only from ISO-certified manufacturers, keeping audit trails for each reagent, and using unopened containers for cell culture setups. Partnering with vendors willing to answer detailed purity questions helps keep buffer-related problems out of the results table. If a batch fails a spec check, disposal beats risk.
Science relies on trust, and that begins with ingredients that meet—or beat—the most demanding standards, whether those come stamped with BP, EP, or USP.
In many labs, the success of cell culture or injectable formulation often rides on one simple question: does the product meet safety and purity requirements? Growing up in a family of healthcare workers, I've watched protocols get stricter, and failure to meet standards shuts down entire batches. For cell culture, even a trace of contamination ruins weeks of effort. In the injectable space, a misstep threatens patient safety. The stakes aren’t theoretical; they are deeply personal for someone waiting for treatment or a researcher pushing to find answers.
Regulatory agencies like the FDA draw a bold line: only materials that hit the right purity and sterility standards should touch these applications. Cell culture products must be free from endotoxins, heavy metals, mycoplasma, and other biological contaminants. For injectables, the bar gets higher, calling for validation by good manufacturing practice (GMP) status, tight control on pyrogen levels, and rigorous traceability. One time, a batch of supposedly “highly pure” reagent failed a mycoplasma screen in our research group. That setback cost not just time, but also trust and funding. Confidence in the product disappears fast when standards are ignored.
There’s no substitute for checking the grade. Products may come labeled as ‘reagent grade’, ‘laboratory grade’, ‘cell culture grade’, or ‘pharmaceutical grade’. Each label tells a different story. Lab-grade material often suits general purposes but misses key tests for contaminants that threaten living cells or injectables. Pharmaceutical grade, on the other hand, signals strict controls, certificates of analysis, and compliance with compendia like USP or EP. The difference between a sterile saline bag safe for IV use and one only meant for cleaning glassware lies in these standards, invisible but critical.
It’s tempting to skip over documentation, trusting reputation instead. That shortcut rarely ends well. I’ve seen investigators rush through procurement, only to find missing documentation halts regulatory progress or destroys experimental reproducibility. Certificates of analysis, statements of origin, and sterility reports verify the claims. GMP certification, batch records, and test results build trust not just with regulators but with every scientist and patient down the line.
It’s easy to assume the label covers everything, but real safety starts at procurement. Select vendors with proven track records for cell culture or injectable manufacturing—reputation, transparency, and responsiveness matter more than low cost. Auditing suppliers, reviewing certificates, and verifying compliance before letting products near cells or patients establishes a foundation for success. In my experience, organizations that cut corners on these steps face costly recalls, regulatory penalties, and loss of credibility. Teams that invest in quality save themselves heartache and secure the trust of colleagues and patients.
These aren’t abstract debates. At every stage, the demands of cell culture and injectable formulation call for clear, informed choices. For anyone handling biologicals or pharmaceuticals, scrutiny and diligence protect progress, safety, and lives—yours included.
HEPES holds a firm reputation in labs worldwide for its role as a buffer in cell culture, biochemistry, and molecular biology. Many researchers, myself included, rely on HEPES to stabilize pH and keep experiments reproducible. Storage isn’t just an afterthought—life in the lab quickly teaches you that sloppy storage leads to inconsistent results, and in science, repeatable results mean everything. This buffer can break down, change color, or gather unwanted contaminants, so careful handling pays off, especially under tight deadlines and shrinking grant budgets.
From experience, temperature swings threaten delicate chemicals far more than most people notice. HEPES works best at room temperature, kept well below 30°C. In a hot lab, putting it near the window or above a radiator asks for trouble. On a muggy summer afternoon, even a few degrees over the norm can speed up degradation or cause subtle shifts, especially in a busy room where doors fly open all day. The best spot stays dry, shaded, and out of direct light. In my lab, that meant a sturdy cabinet far from heat sources, checked with a thermometer every week.
Humidity might not sound dangerous until a fine powder like HEPES starts clumping. Water exposure opens the door to hydrolysis and even mold. Resealable bottles with tight lids prevent most of these mishaps. I remember watching a classmate leave buffer out after weighing, only to end up with a lumpy mess after a few days. Dust, mistakes with scoops, or bare hands often slip in unnoticed but slowly erode purity, affecting sensitive cell cultures. We adopted single-use spatulas and labeled everything by date—practices that soon paid off in cleaner, more predictable experiments.
Daylight isn’t a friend to most lab reagents. UV light can trigger chemical changes in HEPES, sometimes showing up as a yellow or pink tint over time. Packaging in amber or opaque bottles keeps light out. Labs that invest in light-resistant containers see fewer problems matching control samples to earlier batches. Next to labeling with date of receipt and opening, this step prevents unnecessary troubleshooting later on.
Once HEPES mixes into liquid, the clock ticks faster. Bacterial contamination lurks if solutions sit out or get reused, and temperature stability grows even more important. In my own benchwork, storing filtered HEPES solutions in sterile containers inside a 2–8°C fridge meant fewer headaches, less batch variation, and fewer days lost redoing failed runs. Repeated freeze-thaw cycles—sometimes tempting to stretch a solution—increase the risk of precipitation and introduce particulate matter, so smaller aliquots became standard practice in my lab.
Lab groups thrive on good habits and clear communication. Labeling dates, batch numbers, and handling notes lets everyone know what’s inside the bottle and how old it is. Simple record-keeping saves time and money; unfamiliar bottles hiding in the back cabinet usually spell trouble. Taking storage seriously—from clean tools to periodic quality checks—brings more reliable results, makes compliance audits smoother, and leads to fewer questions about unexpected cell growth or lost dyes in critical experiments.
Solid storage involves conscious choices: cool, dry shelves, light-proof bottles, and disciplined labeling. It isn’t glamorous, but with HEPES, small missteps add up fast. A few extra steps improve buffer quality and support sound science—something any researcher can get behind.
HEPES shows up almost everywhere in biotech labs — from buffer prep to cell culture work. Its status as a pharmaceutical-grade product often pulls strict packaging demands into the conversation. Lab managers notice that poor package selection means lost time and resources, so the way HEPES arrives on the loading dock really matters.
Walking through supplier catalogs, you’ll find HEPES most often offered in container sizes like 500 grams, 1 kilogram, 5 kilograms, and sometimes larger drums running up to 25 or 50 kilograms. For smaller R&D labs, the half-kilogram or 1-kilogram bottles keep inventory fresh and contamination risks lower. Giant production sites, on the other hand, tend to buy the largest drums they can safely store. Trying to break down a big drum for multiple teams causes headaches and inconsistent results.
I’ve seen purchasing teams try to save a few dollars by ordering large drums, only to find that splitting powder into dozens of smaller jars by hand increases the risk of moisture and mix-ups. In environments where GMP (Good Manufacturing Practice) compliance comes into play, original sealed packaging gives much needed traceability and peace of mind. For many sterile facilities, it’s worth insisting on single-use, tamper-evident packs to reduce unnecessary handling and support audit trails.
Pharmaceutical grade HEPES almost always ships in high-density polyethylene (HDPE) bottles or polypropylene containers. These plastics don’t react with the buffer, and seal out moisture pretty effectively. Cardboard and metal drums can also pop up for very large orders, but powder liners or double-bagging are used to keep water out. Cardboard soaks up humidity, so it’s a backup rather than first choice for long-term storage.
HDPE and polypropylene both earned their top spots by beating glass on safety and weight. Dropping a plastic bottle in a sterile suite spells less disaster than sweeping up glass. A tight-fitting screw lid with an inner seal can keep the powder dry for months. Some companies now offer pre-weighed pouches, which slot directly into automated weighing stations, shaving down time spent on the scale and reducing spills. In cleanroom settings, every movement matters: the fewer steps needed, the lower the risk.
Health authorities expect pharmaceutical grade HEPES to ship in packages clearly labeled with lot numbers, expiration dates, and manufacturing details. Tamper-evident seals aren’t just red tape; they form the backbone of complaint investigations when something seems off. Audit teams don’t have much patience for faded labels or marks that rub away with a gloved hand. I remember reviewing a batch history only to find the batch code missing, making product recall nearly impossible if something went wrong. Standardizing failproof labeling (stickers that survive ethanol wipes and rough handling) saves stress and keeps systems tight.
Some labs could benefit from more flexible pack sizes, such as smaller ready-to-use pods or pods sealed under nitrogen to fight degradation from air. Producers that invite feedback about what works and what misses the mark—whether it’s pack size or label durability—tend to attract loyal users. With HEPES demand staying strong, thoughtful innovation in packaging goes a lot further than keeping an eye on price per kilogram.
Making a thoughtful choice about HEPES packs pays off by reducing waste, making inventory checks straightforward, and supporting safe, repeatable science. Both small and large batch users stand to gain by staying in close communication with suppliers and regulatory experts. After all, details matter most where precision counts.
| Names | |
| Preferred IUPAC name | 4-[2-hydroxyethyl]piperazine-1-ethanesulfonic acid |
| Other names |
HEPES N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid Hepes Free Acid |
| Pronunciation | /ˈfɔːr haɪˌdrɒksiˌɛθəl pɪˈpɛrəziːn ˌiːˈθeɪnˌsʌlˈfɒnɪk ˈæsɪd/ |
| Identifiers | |
| CAS Number | 7365-45-9 |
| Beilstein Reference | 3583660 |
| ChEBI | CHEBI:39054 |
| ChEMBL | CHEMBL1377 |
| ChemSpider | 67115 |
| DrugBank | DB03766 |
| ECHA InfoCard | 100.087.463 |
| EC Number | EC 213-386-6 |
| Gmelin Reference | 82262 |
| KEGG | C05634 |
| MeSH | D020091 |
| PubChem CID | 7039 |
| RTECS number | TD1275000 |
| UNII | Y9Y9397RK0 |
| UN number | Not regulated |
| Properties | |
| Chemical formula | C8H18N2O4S |
| Molar mass | 238.3 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.083 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -3.3 |
| Vapor pressure | 0.0000146 mmHg at 25°C |
| Acidity (pKa) | 7.5 |
| Basicity (pKb) | 7.5 |
| Magnetic susceptibility (χ) | -7.6×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.511 |
| Viscosity | Viscosity: 2.12 cP |
| Dipole moment | 6.44 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 337.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -1163.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3115 kJ/mol |
| Hazards | |
| Main hazards | Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes serious eye irritation. |
| Precautionary statements | P261, P264, P280, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | 1-0-0-W |
| Lethal dose or concentration | LD50 (oral, rat) > 10,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse (oral) LD50 = 16,930 mg/kg |
| NIOSH | SD6780000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 35 mg/m³ |
| IDLH (Immediate danger) | Not Established |
| Related compounds | |
| Related compounds |
HEPES PIPES MES MOPS ACES TES Tris TAPS |
Chengguan District, Lanzhou, Gansu, China
